Herborium Group, Inc. (HBRM)
OTCMKTS · Delayed Price · Currency is USD
0.0001
+0.0001 (100.00%)
At close: Jul 18, 2025

Herborium Group Company Description

Herborium Group, Inc., a botanical therapeutics company, develops, licenses, and markets proprietary, botanical based medicinal products to consumers and healthcare professionals.

It offers dermatology products, which include AcnEase, herbal medicinal product for enhancing conditions associated with hormonal acne and multiple symptoms of Rosacea; and AcnEase Skin Management System for the treatment of acne marks/scars.

The company also provides sexual health and performance products that are non-prescriptive alternatives to selected sexual disorders resulting from cardiovascular disease, use of anti-depressants, and surgical procedures, including hysterectomy.

In addition, it offers energy restoration products, such as Lasting Energy, a herbal supplement to decrease the symptoms associated with hangovers and eliminating jet-lag; and for treating overall depletion of energy due to competitive sports, high levels of stress, and extensive sexual activities, as well as other long term or temporary physical demands.

Further, the company provides Liver Activator Series for the treatment of liver damage; ProstAid, a natural product focuses on Benign Prostate Hyperplasia; and CardioVitae, a fermentation based product using a Lucidium derived cell line targeting cardio-pulmonary insufficiencies.

Herborium Group, Inc. sells its products in the United States, the United Kingdom, and continental Europe through a network of distributors, specialty retailers, and e-commerce.

The company was founded in 2000 and is headquartered in Fort Lee, New Jersey.

Herborium Group, Inc.
CountryUnited States
Founded2000
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Employees5
CEOAgnes Olszewski

Contact Details

Address:
One Bridge Plaza North
Fort Lee, Nevada 07024
United States
Phone201-849-4431
Websiteherborium.com

Stock Details

Ticker SymbolHBRM
ExchangeOTCMKTS
Stock TypeCommon Stock
Fiscal YearDecember - November
Reporting CurrencyUSD
ISIN NumberUS42703A2087
SIC Code2834

Key Executives

NamePosition
Dr. Agnes P. Olszewski MBA, Ph.D.Founder, Chairman, Chief Executive Officer, President, Chief Financial Officer and Principal Accounting Officer
Dr. James P. Gilligan MSIB, Ph.D.Co-Founder, Scientific Advisor and Director
Daniel TeoSenior Vice President of Business Development
Lawrence WooAsia Business Advisor and Director
Roger Jones OBEUK and EU Advisor and Director
John E. DonahueController and SEC Advisor